Risk Factors and Application of Risk Management Strategies in Hemodialysis Patients Complicated With Heart Failure

NACompletedINTERVENTIONAL
Enrollment

170

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

January 1, 2024

Study Completion Date

January 30, 2024

Conditions
HemodialysisHeart Failure
Interventions
OTHER

Standard Care Group

"Patients in this group received conventional hemodialysis care, including:~Continuous monitoring of vital signs (blood pressure, respiratory rate, pulse, heart rhythm); Supplemental oxygen therapy as needed; Instruction on effective coughing techniques; Strict fluid and electrolyte management; Metabolic support therapies; Positional adjustments (upright posture with lower limb dependency); Environmental regulation (temperature: 22-24°C; humidity: 50-60%); Individualized dietary counseling."

OTHER

Risk-Stratified Management Group

"Patients in this group received standard care plus targeted risk management interventions:~System Enhancement:~Standardized nursing protocols and accountability frameworks Competency-based staff training (emergency response, fluid management) Individualized care plans (e.g., intensified glycemic control for diabetics, optimized BP monitoring for hypertensives)~Risk Stratification:~Admission assessments and follow-up evaluations to identify high-risk patients Hemodynamic monitoring with alert thresholds for early deterioration detection Strict pharmacological supervision and fluid balance protocols~Environmental Modification:~Optimized dialysis unit conditions (temperature: 22-24°C; humidity: 50-60%) Dedicated cardiac care zones for HF patients~Quality Control:~Quarterly audits of critical care domains (patient education, vital signs documentation, protocol compliance, satisfaction metrics) Corrective actions for identified deficiencies"

Trial Locations (1)

Unknown

Changsha Fourth Hospital, Changsha

All Listed Sponsors
lead

Guiren Hou

OTHER_GOV

NCT06959927 - Risk Factors and Application of Risk Management Strategies in Hemodialysis Patients Complicated With Heart Failure | Biotech Hunter | Biotech Hunter